Source: Arrone, et al New England J of Medicine May 11, 2025 Researchers randomized about 1,500 people with obesity and without diabetes to be treated with either tirzepatide or semaglutide, both at the highest tolerable recommended doses, and followed them for 72 weeks
Salcaprozoate helps poorly soluble large molecules, such as semaglutide (but also others such as insulin or heparin), to be absorbed, offering a more convenient way for medications to be taken that are typically given by injection
In this situation, adipocytes encountering high insulin and low GH levels can only store nutrients and not start lipolysis, the ideal situation for gaining weight instead of losing it
By modulating these receptors, tirzepatide can help individuals consume fewer calories and experience increased feelings of fullness, contributing to the reduction in body weight
Together, the figure highlights the mechanisms and functional advantages of each platform for cancer-targeted therapies
X.ChangB.WangB